Delivery Order SPE2DR25D3303-SPE2DR26F65F0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,207.06 to AmerisourceBergen Drug Corp for 30 tablets of Disulfiram 250 mg, with an ultimate completion date of November 7, 2025. This competitive award, issued on November 6, 2025, utilizes firm fixed pricing and carries no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,713.71 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Disulfiram 250 mg, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Disulfiram 250 mg tablets, a pharmaceutical product, with a potential value of $1,389.55. This is a firm fixed price delivery order contract with a completion date of January 3, 2024. No set-aside designation was used for this...
- This federal contract award to Amerisourcebergen Drug Corp from the Defense Logistics Agency (DLA) Troop Support Medical is for the supply of 4,565,678,670 tablets of Disulfiram 250 mg. The award, identified as SPE2DB22D2006|SPE2DB24FW3GK, is a Delivery Order with a Firm Fixed Price of $1,911.70. The contract has an ultimate completion date of September 5, 2024 and was awarded on September 4, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 27, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside order carries a ceiling value of $4,072.48 and is structured as a firm fixed-price delivery order with an ultimate completion date of December 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Naltrexone 50 mg tablets (100-count units) with a contract ceiling value of $1,700.58. This firm fixed-price delivery order, which is set to be completed by October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a $2,744.80 delivery order to AmerisourceBergen Drug Corp for Naltrexone 50 mg tablets (100-count units) with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a standard pharmaceutical procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Naltrexone 50 mg tablets in quantities of 100 units, with a ceiling value of $3,908.57 and an ultimate completion date of December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,319.92 to supply Aplenzin ER 348 mg tablets (30-count) under a firm fixed price contract. The award, issued December 16, 2025, with completion targeted for December 17, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,217.28 delivery order is for 180 tablets of acamprosate calcium delayed-release 333 mg, a medication used to treat alcohol dependence. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F65F0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp for 100 tablets of Disulfiram 250 mg, a medication used primarily in alcohol use disorder treatment. This firm fixed-price delivery order, valued at $1,165.86, was awarded on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerSourceBergen), is a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The underlying IDC demonstrates the contractor's significant role in the Defense Logistics Agency's medical supply chain and its capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/7/26 |